Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 180 | 2024 | 1285 | 30.240 |
Why?
|
Embolization, Therapeutic | 137 | 2024 | 1418 | 20.640 |
Why?
|
Aneurysm, Ruptured | 43 | 2024 | 464 | 9.140 |
Why?
|
Subarachnoid Hemorrhage | 88 | 2024 | 1033 | 9.080 |
Why?
|
Endovascular Procedures | 71 | 2024 | 2182 | 8.000 |
Why?
|
Intracranial Arteriovenous Malformations | 42 | 2024 | 366 | 7.400 |
Why?
|
Hematoma, Subdural, Chronic | 20 | 2024 | 95 | 6.530 |
Why?
|
Cerebral Revascularization | 22 | 2024 | 259 | 6.200 |
Why?
|
Cerebral Angiography | 84 | 2024 | 1281 | 4.840 |
Why?
|
Central Nervous System Vascular Malformations | 22 | 2023 | 140 | 4.730 |
Why?
|
Meningeal Arteries | 20 | 2024 | 68 | 4.590 |
Why?
|
Moyamoya Disease | 13 | 2024 | 265 | 4.250 |
Why?
|
Stents | 44 | 2024 | 3178 | 4.230 |
Why?
|
Neurosurgical Procedures | 36 | 2024 | 2067 | 3.760 |
Why?
|
Vasospasm, Intracranial | 26 | 2024 | 214 | 3.190 |
Why?
|
Carotid Artery, Internal | 25 | 2024 | 445 | 3.100 |
Why?
|
Microsurgery | 15 | 2024 | 793 | 3.060 |
Why?
|
Carotid-Cavernous Sinus Fistula | 5 | 2023 | 37 | 2.840 |
Why?
|
Platelet Aggregation Inhibitors | 20 | 2024 | 2745 | 2.680 |
Why?
|
Aneurysm | 9 | 2023 | 337 | 2.390 |
Why?
|
Thrombectomy | 16 | 2022 | 702 | 2.380 |
Why?
|
Angiography, Digital Subtraction | 26 | 2021 | 335 | 2.360 |
Why?
|
Treatment Outcome | 172 | 2024 | 64568 | 2.210 |
Why?
|
Craniotomy | 21 | 2023 | 741 | 2.190 |
Why?
|
Vertebral Artery | 13 | 2024 | 184 | 2.180 |
Why?
|
Platelet Function Tests | 5 | 2024 | 271 | 2.020 |
Why?
|
Surgical Instruments | 14 | 2024 | 383 | 1.960 |
Why?
|
Carotid Artery Diseases | 10 | 2023 | 877 | 1.920 |
Why?
|
Cerebral Hemorrhage | 22 | 2020 | 2641 | 1.710 |
Why?
|
Temporal Arteries | 4 | 2024 | 154 | 1.690 |
Why?
|
Thromboembolism | 9 | 2024 | 991 | 1.680 |
Why?
|
Arteriovenous Fistula | 10 | 2023 | 319 | 1.660 |
Why?
|
Radiosurgery | 15 | 2024 | 1339 | 1.630 |
Why?
|
Retrospective Studies | 170 | 2024 | 80566 | 1.620 |
Why?
|
Blood Vessel Prosthesis | 18 | 2023 | 951 | 1.620 |
Why?
|
Intracranial Hypertension | 3 | 2022 | 193 | 1.560 |
Why?
|
Propensity Score | 13 | 2024 | 1911 | 1.530 |
Why?
|
Postoperative Complications | 55 | 2024 | 15612 | 1.520 |
Why?
|
Pseudotumor Cerebri | 2 | 2022 | 108 | 1.480 |
Why?
|
Middle Aged | 239 | 2024 | 220584 | 1.470 |
Why?
|
Decompression, Surgical | 8 | 2017 | 606 | 1.460 |
Why?
|
Brain Ischemia | 30 | 2024 | 3028 | 1.440 |
Why?
|
Humans | 446 | 2024 | 760617 | 1.440 |
Why?
|
Cerebrovascular Disorders | 13 | 2020 | 1474 | 1.430 |
Why?
|
Vertebral Artery Dissection | 3 | 2024 | 48 | 1.420 |
Why?
|
Magnetic Resonance Angiography | 22 | 2021 | 1431 | 1.390 |
Why?
|
Aneurysm, False | 4 | 2014 | 255 | 1.360 |
Why?
|
Neurosurgery | 7 | 2024 | 679 | 1.310 |
Why?
|
Stroke | 26 | 2024 | 9712 | 1.290 |
Why?
|
Cerebral Veins | 3 | 2022 | 157 | 1.180 |
Why?
|
Male | 271 | 2024 | 360358 | 1.180 |
Why?
|
Aged | 179 | 2024 | 169042 | 1.170 |
Why?
|
Cerebrospinal Fluid Shunts | 5 | 2022 | 195 | 1.160 |
Why?
|
Female | 276 | 2024 | 392148 | 1.150 |
Why?
|
Transverse Sinuses | 4 | 2021 | 25 | 1.130 |
Why?
|
Posterior Cerebral Artery | 2 | 2024 | 35 | 1.080 |
Why?
|
Spinal Cord Diseases | 4 | 2023 | 291 | 1.070 |
Why?
|
Collateral Circulation | 3 | 2024 | 293 | 1.060 |
Why?
|
Ophthalmic Artery | 5 | 2023 | 58 | 1.060 |
Why?
|
Drainage | 12 | 2023 | 1156 | 1.060 |
Why?
|
Vertebrobasilar Insufficiency | 5 | 2016 | 113 | 1.020 |
Why?
|
Off-Label Use | 4 | 2024 | 185 | 1.020 |
Why?
|
Aspirin | 8 | 2024 | 3127 | 1.010 |
Why?
|
Adult | 179 | 2024 | 220969 | 1.010 |
Why?
|
Intracranial Thrombosis | 5 | 2020 | 108 | 0.990 |
Why?
|
Carotid Stenosis | 11 | 2023 | 859 | 0.930 |
Why?
|
Middle Cerebral Artery | 6 | 2021 | 274 | 0.900 |
Why?
|
Hemangioma, Cavernous | 8 | 2003 | 107 | 0.890 |
Why?
|
Vascular Surgical Procedures | 14 | 2024 | 1489 | 0.880 |
Why?
|
Polyvinyls | 8 | 2020 | 154 | 0.870 |
Why?
|
Cerebellum | 9 | 2015 | 1501 | 0.870 |
Why?
|
Hematoma | 5 | 2015 | 762 | 0.860 |
Why?
|
Platelet Aggregation | 2 | 2024 | 771 | 0.850 |
Why?
|
Follow-Up Studies | 60 | 2024 | 39063 | 0.790 |
Why?
|
Dimethyl Sulfoxide | 7 | 2020 | 251 | 0.780 |
Why?
|
Cerebral Arteries | 11 | 2015 | 490 | 0.740 |
Why?
|
Papilledema | 1 | 2022 | 130 | 0.740 |
Why?
|
Anterior Cerebral Artery | 5 | 2024 | 50 | 0.730 |
Why?
|
Conscious Sedation | 3 | 2017 | 531 | 0.720 |
Why?
|
Ventriculostomy | 5 | 2021 | 131 | 0.690 |
Why?
|
Basilar Artery | 7 | 2016 | 205 | 0.690 |
Why?
|
Hydrocephalus | 11 | 2022 | 764 | 0.680 |
Why?
|
Decompressive Craniectomy | 3 | 2017 | 76 | 0.680 |
Why?
|
Cerebral Infarction | 14 | 2024 | 980 | 0.660 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2023 | 3244 | 0.660 |
Why?
|
Cost-Benefit Analysis | 5 | 2024 | 5491 | 0.640 |
Why?
|
Drug Resistance | 1 | 2024 | 1594 | 0.600 |
Why?
|
Ischemic Attack, Transient | 10 | 2014 | 874 | 0.600 |
Why?
|
Hypertension | 9 | 2024 | 8529 | 0.600 |
Why?
|
Aged, 80 and over | 59 | 2024 | 58894 | 0.590 |
Why?
|
Ventriculoperitoneal Shunt | 6 | 2020 | 187 | 0.580 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 2 | 2019 | 56 | 0.580 |
Why?
|
Angioplasty, Balloon | 4 | 2017 | 589 | 0.580 |
Why?
|
Glasgow Outcome Scale | 8 | 2006 | 104 | 0.570 |
Why?
|
Cerebrovascular Circulation | 19 | 2021 | 2726 | 0.550 |
Why?
|
Mucopolysaccharidosis II | 1 | 2016 | 26 | 0.550 |
Why?
|
Nervous System Diseases | 6 | 2016 | 1662 | 0.530 |
Why?
|
Spinal Cord Neoplasms | 4 | 2005 | 261 | 0.530 |
Why?
|
Indocyanine Green | 2 | 2016 | 233 | 0.530 |
Why?
|
Spinal Cord | 10 | 2022 | 1807 | 0.530 |
Why?
|
Medulla Oblongata | 1 | 2017 | 248 | 0.520 |
Why?
|
Carotid Artery, External | 1 | 2015 | 37 | 0.510 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2017 | 110 | 0.510 |
Why?
|
Brain Stem | 5 | 2011 | 858 | 0.500 |
Why?
|
Arterial Occlusive Diseases | 5 | 2022 | 748 | 0.500 |
Why?
|
Central Nervous System Infections | 1 | 2015 | 61 | 0.490 |
Why?
|
Brain Stem Neoplasms | 2 | 2010 | 190 | 0.490 |
Why?
|
Tobacco Smoke Pollution | 1 | 2020 | 819 | 0.470 |
Why?
|
alpha-Macroglobulins | 1 | 2014 | 60 | 0.470 |
Why?
|
Catheters | 4 | 2021 | 423 | 0.460 |
Why?
|
Apolipoproteins A | 1 | 2014 | 95 | 0.460 |
Why?
|
Catheterization | 6 | 2021 | 1428 | 0.450 |
Why?
|
Stereotaxic Techniques | 2 | 2015 | 555 | 0.450 |
Why?
|
Headache | 7 | 2022 | 1255 | 0.450 |
Why?
|
Tomography, X-Ray Computed | 45 | 2023 | 20556 | 0.440 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2014 | 149 | 0.440 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2018 | 1426 | 0.430 |
Why?
|
Bone Plates | 1 | 2016 | 464 | 0.430 |
Why?
|
Cavernous Sinus | 4 | 2002 | 123 | 0.420 |
Why?
|
Head Injuries, Closed | 1 | 2014 | 133 | 0.420 |
Why?
|
Cohort Studies | 41 | 2022 | 41457 | 0.420 |
Why?
|
Length of Stay | 6 | 2024 | 6418 | 0.420 |
Why?
|
Anesthesia, General | 3 | 2020 | 1173 | 0.420 |
Why?
|
Education, Distance | 1 | 2016 | 259 | 0.420 |
Why?
|
Cranial Fossa, Posterior | 3 | 2001 | 135 | 0.410 |
Why?
|
Hematoma, Subdural | 2 | 2023 | 127 | 0.410 |
Why?
|
Triage | 1 | 2019 | 983 | 0.400 |
Why?
|
Intraoperative Complications | 6 | 2018 | 1161 | 0.400 |
Why?
|
Recurrence | 19 | 2020 | 8426 | 0.390 |
Why?
|
Nicardipine | 3 | 2008 | 60 | 0.390 |
Why?
|
Biopolymers | 1 | 2012 | 183 | 0.380 |
Why?
|
Risk Factors | 35 | 2024 | 74115 | 0.380 |
Why?
|
Patient Transfer | 1 | 2018 | 793 | 0.380 |
Why?
|
Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.370 |
Why?
|
Young Adult | 25 | 2024 | 59179 | 0.370 |
Why?
|
Students, Medical | 1 | 2024 | 1934 | 0.370 |
Why?
|
Monitoring, Intraoperative | 3 | 2014 | 941 | 0.370 |
Why?
|
Comprehension | 1 | 2016 | 620 | 0.370 |
Why?
|
Curriculum | 1 | 2024 | 3738 | 0.360 |
Why?
|
Prosthesis Failure | 2 | 2018 | 1204 | 0.350 |
Why?
|
North America | 5 | 2022 | 1273 | 0.350 |
Why?
|
Fibrinolytic Agents | 7 | 2018 | 2073 | 0.350 |
Why?
|
Ticlopidine | 4 | 2018 | 730 | 0.340 |
Why?
|
Magnetic Resonance Imaging | 37 | 2024 | 36402 | 0.340 |
Why?
|
Seizures | 10 | 2014 | 2954 | 0.330 |
Why?
|
Craniopharyngioma | 1 | 2012 | 276 | 0.330 |
Why?
|
Fibrin | 1 | 2012 | 507 | 0.330 |
Why?
|
Paresis | 3 | 2019 | 176 | 0.330 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2012 | 2270 | 0.330 |
Why?
|
Cerebral Aqueduct | 2 | 2002 | 40 | 0.330 |
Why?
|
Prospective Studies | 33 | 2024 | 54360 | 0.320 |
Why?
|
Medical Errors | 1 | 2017 | 1263 | 0.320 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2014 | 739 | 0.320 |
Why?
|
Faculty, Medical | 1 | 2017 | 1204 | 0.320 |
Why?
|
Progesterone | 2 | 2015 | 742 | 0.320 |
Why?
|
Disease Management | 3 | 2018 | 2506 | 0.320 |
Why?
|
Cauda Equina | 2 | 2006 | 45 | 0.310 |
Why?
|
Reoperation | 11 | 2019 | 4300 | 0.310 |
Why?
|
Combined Modality Therapy | 13 | 2024 | 8516 | 0.310 |
Why?
|
Radiculopathy | 1 | 2010 | 201 | 0.310 |
Why?
|
Arteries | 8 | 2024 | 1122 | 0.310 |
Why?
|
Ultrasonography, Doppler, Transcranial | 6 | 2015 | 281 | 0.300 |
Why?
|
American Heart Association | 4 | 2011 | 1039 | 0.300 |
Why?
|
Heparin | 2 | 2005 | 1632 | 0.300 |
Why?
|
Anticoagulants | 6 | 2023 | 4785 | 0.300 |
Why?
|
Hypothermia, Induced | 5 | 2004 | 753 | 0.300 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 285 | 0.300 |
Why?
|
Retreatment | 5 | 2018 | 596 | 0.290 |
Why?
|
Anesthesia, Local | 1 | 2010 | 277 | 0.290 |
Why?
|
Severity of Illness Index | 13 | 2018 | 15828 | 0.290 |
Why?
|
Rabbits | 13 | 2012 | 4770 | 0.290 |
Why?
|
Clinical Protocols | 2 | 2022 | 1437 | 0.290 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1096 | 0.290 |
Why?
|
Laminectomy | 2 | 2023 | 225 | 0.280 |
Why?
|
Imaging, Three-Dimensional | 5 | 2016 | 4058 | 0.280 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2017 | 10 | 0.280 |
Why?
|
Spinal Fusion | 1 | 2016 | 1275 | 0.280 |
Why?
|
Arteriovenous Malformations | 4 | 1999 | 396 | 0.280 |
Why?
|
Drug-Eluting Stents | 2 | 2010 | 681 | 0.280 |
Why?
|
Treatment Failure | 6 | 2024 | 2635 | 0.280 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2012 | 4341 | 0.270 |
Why?
|
Ischemia | 4 | 2003 | 1884 | 0.270 |
Why?
|
Neurologic Examination | 8 | 2015 | 915 | 0.270 |
Why?
|
Circle of Willis | 4 | 2021 | 78 | 0.270 |
Why?
|
Predictive Value of Tests | 15 | 2021 | 15251 | 0.270 |
Why?
|
Intracranial Hemorrhages | 5 | 2019 | 809 | 0.270 |
Why?
|
Retina | 4 | 1998 | 2655 | 0.270 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2315 | 0.260 |
Why?
|
Brain Injuries | 3 | 2013 | 2053 | 0.260 |
Why?
|
Brain Edema | 4 | 2014 | 604 | 0.260 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1737 | 0.260 |
Why?
|
Cerebral Cortex | 4 | 2015 | 5776 | 0.260 |
Why?
|
Intensive Care Units | 1 | 2019 | 3742 | 0.260 |
Why?
|
Hemodilution | 4 | 1997 | 120 | 0.260 |
Why?
|
Hemangioblastoma | 2 | 2011 | 62 | 0.250 |
Why?
|
Estrogen Replacement Therapy | 1 | 2012 | 1208 | 0.250 |
Why?
|
Papaverine | 1 | 2005 | 45 | 0.250 |
Why?
|
Adolescent | 35 | 2024 | 88234 | 0.250 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2371 | 0.250 |
Why?
|
Radiography | 14 | 2023 | 6961 | 0.250 |
Why?
|
Quality-Adjusted Life Years | 2 | 2022 | 1722 | 0.240 |
Why?
|
Calcium Channel Blockers | 3 | 2015 | 694 | 0.240 |
Why?
|
Carotid Artery, Common | 2 | 2013 | 175 | 0.240 |
Why?
|
Radiographic Image Enhancement | 3 | 2008 | 876 | 0.240 |
Why?
|
Diagnostic Imaging | 2 | 2016 | 3527 | 0.240 |
Why?
|
Paraplegia | 1 | 2005 | 161 | 0.240 |
Why?
|
Brain Damage, Chronic | 3 | 2000 | 266 | 0.240 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2004 | 54 | 0.230 |
Why?
|
Child, Preschool | 13 | 2024 | 42188 | 0.230 |
Why?
|
Child | 30 | 2024 | 80079 | 0.230 |
Why?
|
Accreditation | 2 | 2018 | 473 | 0.230 |
Why?
|
Consensus | 2 | 2024 | 3117 | 0.230 |
Why?
|
Diffusion of Innovation | 1 | 2009 | 729 | 0.230 |
Why?
|
Balloon Occlusion | 3 | 2003 | 125 | 0.230 |
Why?
|
Blood Pressure | 12 | 2020 | 8472 | 0.230 |
Why?
|
Academies and Institutes | 2 | 2016 | 318 | 0.230 |
Why?
|
Pancreatic Elastase | 1 | 2004 | 127 | 0.230 |
Why?
|
Cranial Sinuses | 2 | 2021 | 68 | 0.230 |
Why?
|
Spinal Puncture | 2 | 2007 | 282 | 0.220 |
Why?
|
Angioplasty | 2 | 2023 | 355 | 0.220 |
Why?
|
Skin Diseases, Genetic | 1 | 2024 | 49 | 0.220 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1600 | 0.220 |
Why?
|
Retinal Vessels | 3 | 1998 | 852 | 0.220 |
Why?
|
Coated Materials, Biocompatible | 1 | 2005 | 311 | 0.220 |
Why?
|
Pregnancy Complications | 2 | 2018 | 2948 | 0.220 |
Why?
|
Encephalocele | 2 | 2002 | 135 | 0.220 |
Why?
|
Video-Assisted Surgery | 1 | 2003 | 51 | 0.220 |
Why?
|
Lipoma | 1 | 2005 | 293 | 0.220 |
Why?
|
Petrous Bone | 1 | 2023 | 85 | 0.210 |
Why?
|
Endarterectomy, Carotid | 5 | 2012 | 554 | 0.210 |
Why?
|
Mesencephalon | 2 | 2003 | 333 | 0.210 |
Why?
|
Glasgow Coma Scale | 7 | 2018 | 579 | 0.210 |
Why?
|
Blood Volume | 3 | 2002 | 547 | 0.210 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 14648 | 0.210 |
Why?
|
Tomography, Spiral Computed | 1 | 2004 | 273 | 0.210 |
Why?
|
Internship and Residency | 3 | 2024 | 5878 | 0.210 |
Why?
|
Mexiletine | 2 | 1999 | 30 | 0.210 |
Why?
|
Tomography Scanners, X-Ray Computed | 4 | 2018 | 173 | 0.200 |
Why?
|
Brain Infarction | 1 | 2004 | 289 | 0.200 |
Why?
|
Malpractice | 2 | 2017 | 556 | 0.200 |
Why?
|
Tissue Engineering | 1 | 2012 | 1865 | 0.200 |
Why?
|
Tissue Plasminogen Activator | 2 | 2018 | 1163 | 0.200 |
Why?
|
Phenylephrine | 3 | 2002 | 293 | 0.200 |
Why?
|
Vasodilator Agents | 2 | 2008 | 973 | 0.200 |
Why?
|
United States | 21 | 2022 | 72272 | 0.200 |
Why?
|
Open Bite | 1 | 2021 | 17 | 0.200 |
Why?
|
Patient Care Team | 4 | 2015 | 2515 | 0.200 |
Why?
|
Pia Mater | 1 | 2001 | 87 | 0.190 |
Why?
|
Fourth Ventricle | 1 | 2001 | 32 | 0.190 |
Why?
|
Carotid Artery Injuries | 2 | 2018 | 96 | 0.190 |
Why?
|
Orbit | 1 | 2024 | 457 | 0.190 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2005 | 242 | 0.190 |
Why?
|
Cerebral Arterial Diseases | 1 | 2021 | 82 | 0.180 |
Why?
|
Blood Coagulation Disorders | 1 | 2024 | 350 | 0.180 |
Why?
|
Facial Paralysis | 1 | 2005 | 346 | 0.180 |
Why?
|
Surgical Stapling | 1 | 2021 | 98 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
Patient Selection | 6 | 2020 | 4237 | 0.180 |
Why?
|
Photography | 1 | 2003 | 532 | 0.170 |
Why?
|
Rehabilitation, Vocational | 1 | 2000 | 74 | 0.170 |
Why?
|
Case-Control Studies | 6 | 2024 | 22148 | 0.170 |
Why?
|
Brain Neoplasms | 5 | 2012 | 9026 | 0.170 |
Why?
|
Brain Mapping | 2 | 2015 | 6634 | 0.170 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4433 | 0.170 |
Why?
|
Headache Disorders, Secondary | 2 | 2018 | 34 | 0.170 |
Why?
|
Intracranial Embolism | 2 | 2017 | 187 | 0.170 |
Why?
|
Capsaicin | 2 | 1991 | 232 | 0.170 |
Why?
|
Fishes | 4 | 1988 | 602 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2016 | 8998 | 0.170 |
Why?
|
Colloids | 4 | 2002 | 123 | 0.170 |
Why?
|
Intraoperative Care | 1 | 2003 | 767 | 0.170 |
Why?
|
Logistic Models | 9 | 2020 | 13245 | 0.170 |
Why?
|
Odds Ratio | 8 | 2020 | 9643 | 0.160 |
Why?
|
Decision Trees | 1 | 2021 | 504 | 0.160 |
Why?
|
Nimodipine | 2 | 2015 | 56 | 0.160 |
Why?
|
Intracranial Arteriosclerosis | 2 | 2010 | 138 | 0.160 |
Why?
|
Decision Support Techniques | 2 | 2021 | 1998 | 0.160 |
Why?
|
Hospitalization | 3 | 2024 | 10704 | 0.160 |
Why?
|
Stem Cells | 1 | 2012 | 3516 | 0.160 |
Why?
|
Remission, Spontaneous | 2 | 2015 | 384 | 0.160 |
Why?
|
Sutures | 1 | 2021 | 282 | 0.160 |
Why?
|
Markov Chains | 1 | 2022 | 965 | 0.160 |
Why?
|
Vasoconstrictor Agents | 3 | 2002 | 654 | 0.160 |
Why?
|
Equipment Design | 6 | 2016 | 3501 | 0.160 |
Why?
|
Central Nervous System Diseases | 1 | 2003 | 521 | 0.160 |
Why?
|
Mannitol | 2 | 1996 | 177 | 0.160 |
Why?
|
Radial Artery | 1 | 2020 | 187 | 0.160 |
Why?
|
Angiography | 4 | 2017 | 1596 | 0.160 |
Why?
|
Vascular Malformations | 1 | 2024 | 468 | 0.160 |
Why?
|
Magnesium | 2 | 1999 | 804 | 0.160 |
Why?
|
Neovascularization, Pathologic | 2 | 2024 | 2644 | 0.160 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2849 | 0.150 |
Why?
|
Basal Ganglia | 3 | 2019 | 554 | 0.150 |
Why?
|
Fluoroscopy | 2 | 2009 | 945 | 0.150 |
Why?
|
Animals | 41 | 2024 | 168201 | 0.150 |
Why?
|
Niacinamide | 4 | 2002 | 413 | 0.150 |
Why?
|
Supratentorial Neoplasms | 1 | 1999 | 159 | 0.150 |
Why?
|
Syncope | 2 | 2011 | 428 | 0.150 |
Why?
|
Surgery, Computer-Assisted | 2 | 2016 | 1002 | 0.150 |
Why?
|
Meta-Analysis as Topic | 1 | 2022 | 1380 | 0.150 |
Why?
|
Craniocerebral Trauma | 2 | 2001 | 490 | 0.150 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2020 | 452 | 0.150 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 95 | 0.150 |
Why?
|
Survival Rate | 9 | 2010 | 12719 | 0.140 |
Why?
|
Neurons, Afferent | 2 | 1991 | 498 | 0.140 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2017 | 16 | 0.140 |
Why?
|
Prognosis | 17 | 2021 | 29600 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1349 | 0.140 |
Why?
|
Nitric Oxide | 2 | 1996 | 2135 | 0.140 |
Why?
|
Joint Instability | 1 | 2024 | 801 | 0.140 |
Why?
|
Hematologic Agents | 1 | 2017 | 40 | 0.140 |
Why?
|
Marfan Syndrome | 1 | 2018 | 236 | 0.140 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2000 | 292 | 0.140 |
Why?
|
Neuroprotective Agents | 4 | 2015 | 957 | 0.140 |
Why?
|
Morbidity | 2 | 2021 | 1750 | 0.130 |
Why?
|
Physician Assistants | 1 | 2018 | 190 | 0.130 |
Why?
|
Disease Progression | 6 | 2019 | 13495 | 0.130 |
Why?
|
Sodium | 1 | 2021 | 1588 | 0.130 |
Why?
|
Blood Loss, Surgical | 3 | 2015 | 636 | 0.130 |
Why?
|
False Negative Reactions | 2 | 2013 | 573 | 0.130 |
Why?
|
Europe | 1 | 2023 | 3413 | 0.130 |
Why?
|
Optic Chiasm | 1 | 1996 | 91 | 0.130 |
Why?
|
Equipment Failure Analysis | 1 | 2018 | 843 | 0.130 |
Why?
|
Adenosine | 2 | 2017 | 805 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2005 | 2417 | 0.130 |
Why?
|
Self-Assessment | 1 | 2018 | 398 | 0.130 |
Why?
|
Systems Analysis | 1 | 2016 | 169 | 0.130 |
Why?
|
Nurse Practitioners | 1 | 2018 | 269 | 0.130 |
Why?
|
Age Factors | 7 | 2024 | 18381 | 0.130 |
Why?
|
Costs and Cost Analysis | 2 | 2022 | 1663 | 0.130 |
Why?
|
Cranial Nerve Neoplasms | 2 | 1993 | 134 | 0.120 |
Why?
|
Polytetrafluoroethylene | 1 | 2016 | 245 | 0.120 |
Why?
|
Neuroendoscopy | 1 | 2016 | 99 | 0.120 |
Why?
|
Time Factors | 18 | 2016 | 39913 | 0.120 |
Why?
|
Liability, Legal | 1 | 2016 | 210 | 0.120 |
Why?
|
Mutism | 1 | 1995 | 26 | 0.120 |
Why?
|
Anesthetics | 1 | 2021 | 523 | 0.120 |
Why?
|
Veins | 1 | 2019 | 767 | 0.120 |
Why?
|
Dysarthria | 1 | 1995 | 58 | 0.120 |
Why?
|
Vision, Ocular | 1 | 1998 | 454 | 0.120 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2756 | 0.120 |
Why?
|
Canada | 1 | 2020 | 2118 | 0.120 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1995 | 179 | 0.120 |
Why?
|
Patient Positioning | 1 | 2017 | 326 | 0.120 |
Why?
|
Syndrome | 4 | 2011 | 3268 | 0.120 |
Why?
|
Hypotension | 1 | 2020 | 878 | 0.120 |
Why?
|
Multivariate Analysis | 6 | 2013 | 12043 | 0.120 |
Why?
|
Cornea | 3 | 1991 | 1332 | 0.120 |
Why?
|
United States Food and Drug Administration | 3 | 2022 | 1661 | 0.120 |
Why?
|
Neuropeptide Y | 1 | 1995 | 192 | 0.110 |
Why?
|
Skull | 3 | 2014 | 818 | 0.110 |
Why?
|
Multicenter Studies as Topic | 2 | 2013 | 1700 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 558 | 0.110 |
Why?
|
Third Ventricle | 1 | 2014 | 74 | 0.110 |
Why?
|
Intraoperative Period | 1 | 2015 | 510 | 0.110 |
Why?
|
Lateral Ventricles | 1 | 2015 | 146 | 0.110 |
Why?
|
Trephining | 1 | 1993 | 13 | 0.110 |
Why?
|
Carotid Body Tumor | 1 | 2013 | 34 | 0.110 |
Why?
|
Nerve Fibers | 2 | 1995 | 707 | 0.110 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2017 | 495 | 0.110 |
Why?
|
Lysine | 1 | 1998 | 993 | 0.110 |
Why?
|
Titanium | 1 | 2016 | 485 | 0.110 |
Why?
|
Ectromelia | 1 | 1993 | 28 | 0.110 |
Why?
|
Neuronavigation | 1 | 2015 | 166 | 0.110 |
Why?
|
Intracranial Pressure | 3 | 2002 | 324 | 0.110 |
Why?
|
Neoplasm Seeding | 1 | 1993 | 84 | 0.110 |
Why?
|
Oculomotor Nerve | 1 | 1993 | 72 | 0.110 |
Why?
|
Diagnosis, Differential | 10 | 2014 | 12966 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2017 | 2055 | 0.110 |
Why?
|
Preoperative Care | 2 | 2013 | 2241 | 0.110 |
Why?
|
Antihypertensive Agents | 3 | 2011 | 2016 | 0.110 |
Why?
|
Cerebellar Diseases | 1 | 1995 | 220 | 0.110 |
Why?
|
Cerebellopontine Angle | 1 | 1993 | 53 | 0.110 |
Why?
|
Sirolimus | 2 | 2010 | 1533 | 0.100 |
Why?
|
Ganglionectomy | 2 | 1989 | 11 | 0.100 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 366 | 0.100 |
Why?
|
Risk Assessment | 6 | 2023 | 23972 | 0.100 |
Why?
|
Energy Metabolism | 3 | 2003 | 2878 | 0.100 |
Why?
|
Evoked Potentials, Visual | 1 | 1995 | 417 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2020 | 20074 | 0.100 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1995 | 323 | 0.100 |
Why?
|
Safety | 1 | 2017 | 1149 | 0.100 |
Why?
|
Incidence | 10 | 2018 | 21337 | 0.100 |
Why?
|
Empyema, Subdural | 1 | 1992 | 12 | 0.100 |
Why?
|
Subdural Effusion | 1 | 1992 | 19 | 0.100 |
Why?
|
Aortic Rupture | 1 | 2015 | 319 | 0.100 |
Why?
|
Enbucrilate | 1 | 2012 | 30 | 0.100 |
Why?
|
Databases, Factual | 8 | 2021 | 7960 | 0.100 |
Why?
|
Blindness | 1 | 1996 | 584 | 0.100 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 737 | 0.100 |
Why?
|
Subclavian Steal Syndrome | 1 | 2011 | 20 | 0.100 |
Why?
|
Methylmethacrylates | 1 | 1991 | 67 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2020 | 2689 | 0.100 |
Why?
|
Time | 1 | 2013 | 545 | 0.100 |
Why?
|
Endocarditis, Bacterial | 1 | 2015 | 436 | 0.100 |
Why?
|
Device Approval | 1 | 2013 | 163 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2018 | 1315 | 0.100 |
Why?
|
Contrast Media | 4 | 2013 | 5305 | 0.090 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2012 | 318 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 254 | 0.090 |
Why?
|
Anisotropy | 1 | 2015 | 1283 | 0.090 |
Why?
|
Tomography, Emission-Computed | 1 | 2014 | 1122 | 0.090 |
Why?
|
Hemoglobins | 1 | 1997 | 1524 | 0.090 |
Why?
|
Signal Transduction | 4 | 2024 | 23416 | 0.090 |
Why?
|
Substance Abuse, Intravenous | 1 | 2015 | 529 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
Trigeminal Nerve | 2 | 1991 | 248 | 0.090 |
Why?
|
Isotonic Solutions | 3 | 2002 | 117 | 0.090 |
Why?
|
Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
Pericardium | 1 | 2015 | 664 | 0.090 |
Why?
|
Disease Models, Animal | 8 | 2015 | 18221 | 0.090 |
Why?
|
Mandible | 1 | 1995 | 753 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 1999 | 915 | 0.090 |
Why?
|
Magnetoencephalography | 1 | 2015 | 636 | 0.090 |
Why?
|
Myelography | 2 | 2001 | 72 | 0.090 |
Why?
|
Infusions, Intra-Arterial | 3 | 2008 | 221 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 414 | 0.090 |
Why?
|
Electroretinography | 3 | 1998 | 524 | 0.090 |
Why?
|
Reperfusion | 3 | 2021 | 271 | 0.090 |
Why?
|
Temporal Lobe | 3 | 2011 | 1695 | 0.090 |
Why?
|
Comorbidity | 3 | 2020 | 10505 | 0.090 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2011 | 140 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2014 | 491 | 0.090 |
Why?
|
Regional Blood Flow | 4 | 2004 | 1496 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2013 | 537 | 0.090 |
Why?
|
Societies, Medical | 1 | 2022 | 3900 | 0.090 |
Why?
|
Internationality | 1 | 2015 | 1000 | 0.080 |
Why?
|
Sex Factors | 3 | 2016 | 10548 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10199 | 0.080 |
Why?
|
Hyperglycemia | 3 | 2009 | 1375 | 0.080 |
Why?
|
Electric Stimulation | 1 | 2015 | 1734 | 0.080 |
Why?
|
Meningitis, Bacterial | 1 | 1992 | 221 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1263 | 0.080 |
Why?
|
Medicine | 1 | 2018 | 942 | 0.080 |
Why?
|
Rupture, Spontaneous | 3 | 2011 | 362 | 0.080 |
Why?
|
Cerebellar Neoplasms | 2 | 2011 | 586 | 0.080 |
Why?
|
Iliac Artery | 1 | 2011 | 343 | 0.080 |
Why?
|
Health Personnel | 2 | 2015 | 3333 | 0.080 |
Why?
|
Heart Block | 1 | 2011 | 384 | 0.080 |
Why?
|
Drug Costs | 1 | 2017 | 1183 | 0.080 |
Why?
|
Disability Evaluation | 4 | 2000 | 1835 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 703 | 0.080 |
Why?
|
Inpatients | 1 | 2021 | 2544 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2011 | 4321 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 990 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1115 | 0.080 |
Why?
|
Losartan | 1 | 2011 | 263 | 0.080 |
Why?
|
Angiomatosis | 1 | 1989 | 46 | 0.080 |
Why?
|
Hemodynamics | 4 | 1998 | 4160 | 0.080 |
Why?
|
Publishing | 1 | 2016 | 832 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2016 | 2423 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 26049 | 0.080 |
Why?
|
Periaqueductal Gray | 1 | 1989 | 110 | 0.080 |
Why?
|
Acute Disease | 6 | 2018 | 7237 | 0.080 |
Why?
|
Behavior | 1 | 1991 | 540 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 780 | 0.080 |
Why?
|
Axonal Transport | 1 | 1988 | 178 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 1993 | 1624 | 0.080 |
Why?
|
Electrophysiology | 2 | 2003 | 1262 | 0.080 |
Why?
|
Electroencephalography | 2 | 2014 | 6237 | 0.070 |
Why?
|
Syringomyelia | 1 | 1988 | 67 | 0.070 |
Why?
|
Diagnostic Errors | 2 | 2007 | 1265 | 0.070 |
Why?
|
Hyperemia | 2 | 2004 | 221 | 0.070 |
Why?
|
Head | 3 | 2022 | 922 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1129 | 0.070 |
Why?
|
Plasma Substitutes | 2 | 2002 | 57 | 0.070 |
Why?
|
Confidence Intervals | 2 | 2006 | 2925 | 0.070 |
Why?
|
Anastomosis, Surgical | 1 | 2011 | 982 | 0.070 |
Why?
|
Hospital Mortality | 6 | 2020 | 5293 | 0.070 |
Why?
|
Brain | 11 | 2017 | 27101 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2382 | 0.070 |
Why?
|
Algorithms | 3 | 2021 | 14018 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1779 | 0.070 |
Why?
|
Epilepsy | 1 | 2002 | 3288 | 0.070 |
Why?
|
Hamartoma | 1 | 1989 | 235 | 0.070 |
Why?
|
Cattle | 3 | 2015 | 3841 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11514 | 0.070 |
Why?
|
Postoperative Period | 3 | 2002 | 1813 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5424 | 0.070 |
Why?
|
Patient Discharge | 2 | 2018 | 3442 | 0.070 |
Why?
|
Independent Living | 2 | 2021 | 577 | 0.070 |
Why?
|
Nicotine | 1 | 2011 | 679 | 0.070 |
Why?
|
Microglia | 1 | 2015 | 1357 | 0.070 |
Why?
|
Infarction | 2 | 2022 | 248 | 0.070 |
Why?
|
Arnold-Chiari Malformation | 1 | 1988 | 158 | 0.070 |
Why?
|
Statistical Distributions | 1 | 2006 | 63 | 0.070 |
Why?
|
Blood Physiological Phenomena | 1 | 1986 | 53 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3548 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1213 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14591 | 0.060 |
Why?
|
Simvastatin | 1 | 2008 | 346 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1879 | 0.060 |
Why?
|
Catecholamines | 1 | 1987 | 387 | 0.060 |
Why?
|
Risk | 4 | 2018 | 9604 | 0.060 |
Why?
|
Models, Animal | 1 | 2012 | 2109 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2187 | 0.060 |
Why?
|
Axons | 2 | 1995 | 1671 | 0.060 |
Why?
|
Injections, Intra-Arterial | 1 | 2005 | 181 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 1993 | 1051 | 0.060 |
Why?
|
Parietal Lobe | 1 | 2010 | 852 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 805 | 0.060 |
Why?
|
Platelet Factor 4 | 1 | 2005 | 129 | 0.060 |
Why?
|
Pilot Projects | 6 | 2024 | 8618 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2789 | 0.060 |
Why?
|
Infant | 5 | 2022 | 36152 | 0.060 |
Why?
|
Fever | 2 | 2004 | 1618 | 0.060 |
Why?
|
Vision Disorders | 2 | 2003 | 1088 | 0.060 |
Why?
|
Dominance, Cerebral | 2 | 1997 | 623 | 0.060 |
Why?
|
California | 2 | 2019 | 1430 | 0.060 |
Why?
|
Pain | 1 | 2000 | 5061 | 0.060 |
Why?
|
Fluorescent Dyes | 2 | 1991 | 1901 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2400 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2004 | 6305 | 0.060 |
Why?
|
Databases as Topic | 2 | 2004 | 473 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 2208 | 0.060 |
Why?
|
Norepinephrine | 2 | 2002 | 898 | 0.060 |
Why?
|
Athletic Injuries | 1 | 2014 | 1216 | 0.060 |
Why?
|
Rats, Wistar | 5 | 2000 | 1848 | 0.060 |
Why?
|
Phenobarbital | 1 | 2004 | 191 | 0.060 |
Why?
|
NF-kappa B | 1 | 2012 | 2481 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3879 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8645 | 0.060 |
Why?
|
Motor Neurons | 1 | 1988 | 870 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2010 | 1469 | 0.050 |
Why?
|
Ligation | 1 | 2004 | 447 | 0.050 |
Why?
|
Aorta | 1 | 2011 | 2041 | 0.050 |
Why?
|
Hearing Disorders | 1 | 2003 | 126 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3238 | 0.050 |
Why?
|
Solutions | 2 | 2002 | 412 | 0.050 |
Why?
|
Venous Insufficiency | 1 | 2004 | 108 | 0.050 |
Why?
|
Pregnancy | 5 | 2018 | 29868 | 0.050 |
Why?
|
Electrocardiography | 2 | 2011 | 6346 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Rats | 10 | 2011 | 23717 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2018 | 1575 | 0.050 |
Why?
|
Paclitaxel | 1 | 2010 | 1730 | 0.050 |
Why?
|
Sulfonamides | 2 | 2015 | 1977 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2680 | 0.050 |
Why?
|
Anticonvulsants | 2 | 2018 | 1906 | 0.050 |
Why?
|
Cell Count | 3 | 1991 | 1835 | 0.050 |
Why?
|
Recovery of Function | 4 | 2011 | 2978 | 0.050 |
Why?
|
Aphasia | 1 | 2003 | 192 | 0.050 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2005 | 485 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2018 | 10754 | 0.050 |
Why?
|
Device Removal | 2 | 2018 | 629 | 0.050 |
Why?
|
Carbon Dioxide | 1 | 1986 | 1148 | 0.050 |
Why?
|
Bronchial Spasm | 1 | 1981 | 71 | 0.050 |
Why?
|
Swimming | 1 | 1982 | 208 | 0.050 |
Why?
|
Ataxia | 1 | 2003 | 306 | 0.050 |
Why?
|
Rats, Inbred Strains | 3 | 1991 | 2088 | 0.050 |
Why?
|
Systole | 2 | 2000 | 935 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 230 | 0.050 |
Why?
|
Minnesota | 1 | 2001 | 338 | 0.050 |
Why?
|
Indomethacin | 1 | 1981 | 323 | 0.040 |
Why?
|
Dura Mater | 2 | 2015 | 290 | 0.040 |
Why?
|
Survival Analysis | 4 | 2013 | 10073 | 0.040 |
Why?
|
Heart Rate | 3 | 1988 | 4180 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1033 | 0.040 |
Why?
|
Ascorbic Acid | 2 | 1997 | 655 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5200 | 0.040 |
Why?
|
Respiration | 1 | 1987 | 1656 | 0.040 |
Why?
|
Massachusetts | 2 | 2003 | 8833 | 0.040 |
Why?
|
Airway Resistance | 1 | 1981 | 406 | 0.040 |
Why?
|
Action Potentials | 2 | 1998 | 1825 | 0.040 |
Why?
|
Extracellular Space | 1 | 1982 | 562 | 0.040 |
Why?
|
Meningeal Neoplasms | 1 | 1989 | 1245 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2056 | 0.040 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2019 | 34 | 0.040 |
Why?
|
Hyoid Bone | 1 | 1999 | 38 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2011 | 3095 | 0.040 |
Why?
|
Photic Stimulation | 2 | 1996 | 1987 | 0.040 |
Why?
|
Endarterectomy | 2 | 1997 | 196 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2001 | 293 | 0.040 |
Why?
|
Feasibility Studies | 4 | 2021 | 5239 | 0.040 |
Why?
|
Catheterization, Central Venous | 1 | 2004 | 526 | 0.040 |
Why?
|
Drug Combinations | 2 | 2011 | 2048 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2002 | 539 | 0.040 |
Why?
|
New England | 1 | 2022 | 1051 | 0.040 |
Why?
|
Cyclotrons | 1 | 1998 | 30 | 0.040 |
Why?
|
Erythrocyte Transfusion | 1 | 2003 | 568 | 0.040 |
Why?
|
Emergency Medicine | 1 | 2007 | 1197 | 0.040 |
Why?
|
Quality of Life | 1 | 2000 | 13347 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6483 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7847 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2003 | 1074 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1595 | 0.040 |
Why?
|
Protons | 1 | 2003 | 1112 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1998 | 310 | 0.040 |
Why?
|
Compassionate Use Trials | 1 | 2017 | 50 | 0.040 |
Why?
|
Boston | 2 | 2012 | 9313 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1490 | 0.040 |
Why?
|
Social Adjustment | 1 | 2000 | 632 | 0.040 |
Why?
|
Bipolar Disorder | 1 | 1995 | 5091 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1998 | 322 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1835 | 0.040 |
Why?
|
Prosencephalon | 1 | 1999 | 305 | 0.040 |
Why?
|
Workload | 1 | 2003 | 844 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 3705 | 0.040 |
Why?
|
Thrombosis | 1 | 2011 | 2943 | 0.040 |
Why?
|
Blood Viscosity | 1 | 1997 | 124 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 1997 | 74 | 0.030 |
Why?
|
Cholesterol Esters | 1 | 1997 | 73 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2023 | 976 | 0.030 |
Why?
|
Blood Glucose | 2 | 2009 | 6390 | 0.030 |
Why?
|
Retinal Diseases | 1 | 2003 | 704 | 0.030 |
Why?
|
Optic Nerve | 2 | 2003 | 572 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2021 | 941 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 633 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2012 | 18937 | 0.030 |
Why?
|
Glioblastoma | 1 | 2011 | 3481 | 0.030 |
Why?
|
Radiotherapy | 1 | 2003 | 1497 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10432 | 0.030 |
Why?
|
Netherlands | 1 | 2001 | 2221 | 0.030 |
Why?
|
Hemostatic Techniques | 1 | 1997 | 111 | 0.030 |
Why?
|
Artifacts | 2 | 2009 | 1910 | 0.030 |
Why?
|
South America | 1 | 2016 | 179 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 3085 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2475 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2014 | 2897 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1565 | 0.030 |
Why?
|
Hematocrit | 1 | 1997 | 623 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2022 | 3599 | 0.030 |
Why?
|
Hemorrhage | 1 | 1988 | 3418 | 0.030 |
Why?
|
Ferricyanides | 1 | 1995 | 31 | 0.030 |
Why?
|
Pregnatrienes | 1 | 2015 | 5 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 849 | 0.030 |
Why?
|
Persistent Vegetative State | 1 | 1998 | 273 | 0.030 |
Why?
|
Metalloporphyrins | 1 | 2015 | 41 | 0.030 |
Why?
|
Acute-Phase Reaction | 1 | 2015 | 91 | 0.030 |
Why?
|
Receptor, Endothelin A | 1 | 2015 | 56 | 0.030 |
Why?
|
Dioxanes | 1 | 2015 | 36 | 0.030 |
Why?
|
Thrombophilia | 1 | 2018 | 306 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2003 | 1059 | 0.030 |
Why?
|
Nitroprusside | 1 | 1995 | 272 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 1988 | 2568 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8207 | 0.030 |
Why?
|
Hospitals, General | 1 | 1999 | 798 | 0.030 |
Why?
|
Dopamine | 1 | 2002 | 1606 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2015 | 168 | 0.030 |
Why?
|
Xanthomatosis | 1 | 1994 | 32 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1995 | 260 | 0.030 |
Why?
|
Magnesium Sulfate | 1 | 2015 | 73 | 0.030 |
Why?
|
Leg | 1 | 2000 | 1087 | 0.030 |
Why?
|
Genes | 1 | 1998 | 1823 | 0.030 |
Why?
|
Blood Platelets | 1 | 2005 | 2478 | 0.030 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2017 | 284 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7389 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6593 | 0.030 |
Why?
|
Coma | 1 | 1998 | 484 | 0.030 |
Why?
|
Visual Fields | 2 | 2003 | 1062 | 0.030 |
Why?
|
Cyclosporine | 1 | 1997 | 778 | 0.030 |
Why?
|
Perioperative Care | 1 | 2002 | 1037 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 2015 | 211 | 0.030 |
Why?
|
History, 20th Century | 1 | 2022 | 2764 | 0.030 |
Why?
|
Hyponatremia | 1 | 2016 | 279 | 0.030 |
Why?
|
Paranasal Sinuses | 1 | 1996 | 265 | 0.030 |
Why?
|
Electromagnetic Phenomena | 1 | 2015 | 160 | 0.030 |
Why?
|
Pons | 1 | 1995 | 240 | 0.030 |
Why?
|
Fibrinogen | 1 | 1997 | 887 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 577 | 0.030 |
Why?
|
Epinephrine | 2 | 1988 | 792 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1996 | 908 | 0.030 |
Why?
|
Fiducial Markers | 1 | 2015 | 132 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 359 | 0.030 |
Why?
|
Ischemic Preconditioning | 1 | 2014 | 89 | 0.030 |
Why?
|
Lactic Acid | 1 | 1998 | 1139 | 0.030 |
Why?
|
Coronary Angiography | 2 | 2018 | 4470 | 0.030 |
Why?
|
Maze Learning | 1 | 2015 | 482 | 0.030 |
Why?
|
Drugs, Chinese Herbal | 1 | 2015 | 144 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2001 | 924 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 491 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 168 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1385 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2014 | 311 | 0.030 |
Why?
|
Suture Techniques | 1 | 1997 | 768 | 0.030 |
Why?
|
Granuloma | 1 | 1994 | 328 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 817 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 1994 | 542 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15689 | 0.020 |
Why?
|
Methylmethacrylate | 1 | 1991 | 39 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2015 | 547 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2012 | 198 | 0.020 |
Why?
|
Choroid Plexus | 1 | 1994 | 240 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 1996 | 747 | 0.020 |
Why?
|
Hospital Charges | 2 | 2004 | 350 | 0.020 |
Why?
|
Dextrans | 2 | 1990 | 573 | 0.020 |
Why?
|
Arginine | 1 | 1995 | 933 | 0.020 |
Why?
|
Low Back Pain | 1 | 2000 | 982 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2358 | 0.020 |
Why?
|
Central Nervous System | 1 | 1998 | 1333 | 0.020 |
Why?
|
Cats | 2 | 1989 | 975 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4512 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1635 | 0.020 |
Why?
|
ROC Curve | 2 | 2015 | 3575 | 0.020 |
Why?
|
Tail | 2 | 1982 | 91 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2015 | 927 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5866 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2011 | 151 | 0.020 |
Why?
|
Blinking | 1 | 1991 | 133 | 0.020 |
Why?
|
Cartilage Diseases | 1 | 1992 | 157 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2606 | 0.020 |
Why?
|
Macaca | 1 | 2011 | 410 | 0.020 |
Why?
|
Ultrasonography | 2 | 2020 | 5964 | 0.020 |
Why?
|
Denervation | 1 | 1991 | 265 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4391 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3877 | 0.020 |
Why?
|
Dark Adaptation | 1 | 1990 | 222 | 0.020 |
Why?
|
Drug Administration Schedule | 3 | 2007 | 4845 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 1996 | 1023 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2000 | 2118 | 0.020 |
Why?
|
Phagocytosis | 1 | 2015 | 1526 | 0.020 |
Why?
|
Cysts | 1 | 1994 | 680 | 0.020 |
Why?
|
Warfarin | 1 | 2017 | 1477 | 0.020 |
Why?
|
Bicuculline | 1 | 1989 | 96 | 0.020 |
Why?
|
Tears | 1 | 1991 | 251 | 0.020 |
Why?
|
Tetrazoles | 1 | 2015 | 909 | 0.020 |
Why?
|
Apoptosis | 2 | 2015 | 9476 | 0.020 |
Why?
|
Brain Diseases | 2 | 1995 | 1545 | 0.020 |
Why?
|
Trigeminal Ganglion | 1 | 1989 | 186 | 0.020 |
Why?
|
Histological Techniques | 1 | 1989 | 194 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2016 | 1528 | 0.020 |
Why?
|
Rhodamines | 1 | 1988 | 178 | 0.020 |
Why?
|
Embolism | 1 | 1992 | 399 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1397 | 0.020 |
Why?
|
Phentolamine | 1 | 1988 | 102 | 0.020 |
Why?
|
Critical Care | 2 | 2018 | 2690 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1999 | 2110 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5073 | 0.020 |
Why?
|
Estrogens | 1 | 2015 | 1521 | 0.020 |
Why?
|
Eyelids | 1 | 1990 | 278 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1529 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1989 | 696 | 0.020 |
Why?
|
Aging | 1 | 1987 | 8699 | 0.020 |
Why?
|
Atropine | 1 | 1988 | 244 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2921 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1947 | 0.020 |
Why?
|
Hypercapnia | 1 | 1989 | 261 | 0.020 |
Why?
|
Keratitis | 1 | 1990 | 241 | 0.020 |
Why?
|
Pressure | 2 | 1982 | 1150 | 0.020 |
Why?
|
Reflex | 1 | 1989 | 375 | 0.020 |
Why?
|
Causality | 2 | 2005 | 1240 | 0.020 |
Why?
|
Gadolinium | 1 | 1992 | 959 | 0.020 |
Why?
|
Glucose | 1 | 1998 | 4345 | 0.020 |
Why?
|
Homeostasis | 1 | 1998 | 3321 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 12447 | 0.020 |
Why?
|
Neurilemmoma | 1 | 1992 | 524 | 0.020 |
Why?
|
Regression Analysis | 1 | 1996 | 6338 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3723 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2518 | 0.020 |
Why?
|
Posture | 2 | 1999 | 956 | 0.020 |
Why?
|
Angiotensin II | 1 | 1989 | 849 | 0.020 |
Why?
|
Partial Pressure | 1 | 1986 | 245 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1993 | 1422 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2410 | 0.020 |
Why?
|
Osmotic Pressure | 1 | 1986 | 138 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6224 | 0.020 |
Why?
|
Gold | 1 | 1989 | 481 | 0.020 |
Why?
|
Lung | 1 | 2003 | 9998 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1990 | 2668 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1989 | 1081 | 0.010 |
Why?
|
Shivering | 1 | 2004 | 12 | 0.010 |
Why?
|
Gadolinium DTPA | 1 | 2007 | 823 | 0.010 |
Why?
|
Cisterna Magna | 1 | 2004 | 39 | 0.010 |
Why?
|
Organ Specificity | 1 | 1989 | 1964 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1997 | 4174 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22115 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 1989 | 560 | 0.010 |
Why?
|
Neurons | 2 | 1996 | 9438 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3426 | 0.010 |
Why?
|
Equipment Safety | 1 | 2004 | 249 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2916 | 0.010 |
Why?
|
Pedigree | 2 | 2003 | 4539 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
Pyridines | 1 | 2015 | 2874 | 0.010 |
Why?
|
Blood Flow Velocity | 2 | 1997 | 1370 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1988 | 816 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3680 | 0.010 |
Why?
|
Body Temperature Regulation | 1 | 2004 | 292 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 3027 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3206 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 1988 | 582 | 0.010 |
Why?
|
Dogfish | 1 | 1982 | 11 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2005 | 592 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4789 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 2002 | 186 | 0.010 |
Why?
|
Surgical Flaps | 2 | 2005 | 1670 | 0.010 |
Why?
|
Technology Assessment, Biomedical | 1 | 2004 | 306 | 0.010 |
Why?
|
Methacholine Compounds | 1 | 1981 | 35 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4919 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 880 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11069 | 0.010 |
Why?
|
Codon | 1 | 2003 | 600 | 0.010 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1981 | 144 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2004 | 458 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2009 | 1956 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1986 | 2495 | 0.010 |
Why?
|
Total Lung Capacity | 1 | 1981 | 149 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 2002 | 826 | 0.010 |
Why?
|
Anesthesia | 1 | 2012 | 1591 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2002 | 379 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 2003 | 407 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81368 | 0.010 |
Why?
|
Blood Proteins | 1 | 1986 | 1172 | 0.010 |
Why?
|
Papio | 1 | 2002 | 669 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4416 | 0.010 |
Why?
|
Neural Pathways | 1 | 1991 | 3056 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14389 | 0.010 |
Why?
|
Locomotion | 1 | 1982 | 388 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7402 | 0.010 |
Why?
|
Supine Position | 1 | 1999 | 205 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 600 | 0.010 |
Why?
|
Acceleration | 1 | 1978 | 189 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1999 | 11459 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1376 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 239 | 0.010 |
Why?
|
Cause of Death | 2 | 1999 | 3683 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1982 | 1200 | 0.010 |
Why?
|
Diffusion | 1 | 1999 | 814 | 0.010 |
Why?
|
Thalamus | 1 | 2003 | 1047 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4570 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2002 | 1117 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9311 | 0.010 |
Why?
|
Ubiquinone | 1 | 1997 | 183 | 0.010 |
Why?
|
Ulcer | 1 | 1996 | 203 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2881 | 0.010 |
Why?
|
Ethmoid Sinus | 1 | 1994 | 57 | 0.010 |
Why?
|
Nervous System | 1 | 1998 | 545 | 0.010 |
Why?
|
Dogs | 2 | 1990 | 3838 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2003 | 4110 | 0.010 |
Why?
|
Metals | 1 | 1999 | 719 | 0.010 |
Why?
|
Cranial Sutures | 1 | 1995 | 92 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1996 | 462 | 0.010 |
Why?
|
Sphenoid Sinus | 1 | 1994 | 99 | 0.010 |
Why?
|
Perfusion | 1 | 1999 | 1373 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12334 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2340 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2924 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4242 | 0.010 |
Why?
|
Vitamin E | 1 | 1997 | 872 | 0.010 |
Why?
|
Body Height | 1 | 1978 | 1565 | 0.010 |
Why?
|
Genetic Markers | 1 | 1998 | 2601 | 0.010 |
Why?
|
Reticulin | 1 | 1992 | 19 | 0.010 |
Why?
|
Pharynx | 1 | 1994 | 432 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1995 | 544 | 0.010 |
Why?
|
S100 Proteins | 1 | 1992 | 217 | 0.010 |
Why?
|
Vimentin | 1 | 1992 | 255 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1998 | 1189 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2231 | 0.010 |
Why?
|
Uric Acid | 1 | 1997 | 807 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4611 | 0.010 |
Why?
|
Motor Activity | 1 | 2000 | 2714 | 0.010 |
Why?
|
Weight Gain | 1 | 2000 | 2350 | 0.010 |
Why?
|
Specific Gravity | 1 | 1989 | 18 | 0.010 |
Why?
|
Rheology | 1 | 1990 | 347 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 1999 | 2234 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 2000 | 8166 | 0.000 |
Why?
|
Antioxidants | 1 | 1997 | 1668 | 0.000 |
Why?
|
Genotype | 1 | 2003 | 12978 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1992 | 2561 | 0.000 |
Why?
|
Molecular Weight | 1 | 1990 | 2185 | 0.000 |
Why?
|
Body Weight | 1 | 1978 | 4614 | 0.000 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 1992 | 389 | 0.000 |
Why?
|
Echocardiography | 1 | 2000 | 4987 | 0.000 |
Why?
|
Radiography, Interventional | 1 | 1994 | 1120 | 0.000 |
Why?
|
Heart | 1 | 2000 | 4403 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1990 | 2214 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1989 | 960 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16571 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 2392 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1996 | 3356 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 26180 | 0.000 |
Why?
|
Heart Failure | 1 | 1999 | 11669 | 0.000 |
Why?
|